SubscribeElsewhere on HealthThreads: Breast cancer | Lymphoma | Prostate cancer | Endometrial cancer | Colorectal cancer | Pancreatic cancer | Menopause | Thyroid cancer |
# 2 Blogger
Cancer Consultants
Cancer Consultants (patient.cancerconsultants.com) has great Ovarian cancer news, photos, videos and more
Monday, Aug 24
Many High-risk Women Opt for Preventi...
Many High-risk Women Opt for Preventive Removal of Breasts and Ovaries Inherited mutations in two genes—BRCA1 and BRCA2—have been found to greatly increase the lifetime risk of developing breast and ovarian cancer. ...
Monday, Aug 17
Fertility Preservation Appears to Be ...
Information was collected about 1186 women age 50 or younger who were diagnosed with Stage IA or Stage IC epithelial ovarian cancer between 1988 and 2004 ... New Study Suggests Young Early-Stage Ovarian Cancer Patients Can ...Media Newswire (press release)
Wednesday, Jun 3
Initiating Treatment Due to Elevated CA125 Marker Does Not Improve ...
ID CA125 is an important tumor marker in ovarian cancer and can be measured with a simple blood test. Women who have undergone treatment for ovarian cancer typically have their CA125 levels tested regularly for several years following treatment. ...
Tuesday, May 12
Removal of Ovaries During Hysterectomy for Benign Condition ...
Among women who undergo a hysterectomy for benign (non-cancerous) conditions, many also have their ovaries removed in order to reduce the risk of ovarian cancer. For premenopausal women, removal of the ovaries results in an abrupt drop in both estrogen ...
Thursday, Apr 30
Oophorectomy for Benign Disease Increases Heart- and Cancer ...
ID The strategy of bilateral oophorectomy reduced the risk of breast cancer by 25% and the risk of ovarian cancer by 96%. There were 34 deaths from ovarian cancer in women who had their ovaries left in. However, women who had both ovaries removed had a ...
Tuesday, Apr 28
Alimta® Active Against Platinum-resistant Ovarian Cancer
ID Alimta is chemotherapy drug that has been approved by the US Food and Drug Administration for selected patients with mesothelioma or non–small cell lung cancer. To evaluate Alimta in the treatment of ovarian cancer, researchers conducted a Phase II ...
Wednesday, Apr 22
Addition of Third Chemotherapy Agent Provides No Added Benefit for ...
ID The details of this study were published in the March, 30, 2009 issue of the Journal of Clinical Oncology.1 Initial therapy for advanced ovarian cancer includes treatment with Taxol/ Paraplatin. However, due to such poor long-term outcomes in this ...
Tuesday, Apr 21
Alimta® Has Activity in Platinum-resistant Ovarian Cancer
ID Researchers affiliated with the Gynecologic Oncology Group have reported that Alimta® (permetrexed) has significant activity for the treatment of recurrent platinum-resistant ovarian cancer. The details of this study appeared in an early online ...
Tuesday, Apr 7
Genetic Variants Linked with Risk of Breast Cancer
Elle UK ID Two well known genes that influence the risk of breast and ovarian cancer are BRCA1 and BRCA2. Mutations in these genes account for a relatively small proportion of all cases of breast cancer, however, and researchers hypothesize that many other ...
Wednesday, Mar 25
Questions Remain About Benefit of PSA Screening for Prostate Cancer
eFitnessNow ID The US Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial involved 76693 men.[2] Men in the screened group had annual PSA testing for six years and digital rectal exam for four years. Men in the control group were allowed “usual” care ...
Friday, Mar 6
Avastin® Shows Promise in Treatment of Cervical Cancer
ID Avastin is approved by the Food and Drug Administration for the treatment of non–small cell lung cancer, colorectal cancer, and breast cancer but has activity in a number of tumors including ovarian cancer, small cell lung cancer, brain cancer, ...
